Significant Ownership of Bleichroeder LP
- Signature - Title
- Andrew Gundlach - President and CEO
- Location
- New York, NY
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Bleichroeder LP.
Follow Filing Activity
Follow Bleichroeder LP and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of Bleichroeder LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| First Eagle Real Estate Debt Fund | Class I Common Shares of Beneficial Interest, $0.001 par value | 99% | 1,367,807 | +86% | Bleichroeder LP | 06 Aug 2025 | |||
| LIQT | LiqTech International, Inc. | Common Stock, $0.001 par value | 34% | $1,304,718 | 3,182,239 | 0% | Bleichroeder LP | 26 Mar 2025 | |
| SCND | Scientific Industries, Inc. | Common Stock, $0.05 par value | 21% | $2,009,119 | -$185,000 | 2,715,026 | -8.4% | Bleichroeder LP | 30 Sep 2025 |
| DUOT | Duos Technologies Group, Inc. | Common Shares | 20% | $9,631,578 | 1,504,934 | Bleichroeder LP | 19 Mar 2025 | ||
| INVE | Identiv, Inc. (INVE) | Common Stock, $0.001 par value | 20% | $16,305,879 | 5,079,713 | Bleichroeder LP | 19 Mar 2025 | ||
| IVAC | Intevac, Inc. | Common Shares | 19% | $20,130,897 | 5,039,023 | Bleichroeder LP | 19 Mar 2025 | ||
| MDXH | MDxHealth SA | Ordinary Shares | 15% | $24,220,525 | 7,429,609 | +0.69% | Bleichroeder LP | 19 Mar 2025 | |
| IDN | Intellicheck, Inc. | Common Shares | 11% | $5,391,316 | 2,073,583 | Bleichroeder LP | 19 Mar 2025 | ||
| CUE | Cue Biopharma, Inc. | Common Stock, par value $0.001 per share | 10% | $5,269,789 | 6,127,662 | 0% | Bleichroeder LP | 19 Mar 2025 | |
| EVOK | Evoke Pharma, Inc. | Common Shares | 10% | $63,223 | 158,058 | -81% | Bleichroeder LP | 24 Mar 2025 | |
| CRIS | Curis Inc | Common Shares | 9.9% | $1,636,346 | 1,035,662 | Bleichroeder LP | 31 Mar 2025 | ||
| FLNT | Fluent, Inc. | Common Shares | 9.6% | $6,342,855 | 2,857,142 | Bleichroeder LP | 30 Sep 2025 | ||
| BRFH | Barfresh Food Group Inc. | Common Shares | 8.8% | $3,838,492 | +$653,687 | 1,390,758 | +21% | Bleichroeder LP | 24 Mar 2025 |
| DTIL | PRECISION BIOSCIENCES INC | Common Shares | 8.2% | $7,809,000 | +$3,390,750 | 1,900,000 | +77% | Bleichroeder LP | 31 Dec 2025 |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES ORD | Common Shares | 8% | $2,800,000 | 4,000,000 | Bleichroeder LP | 30 Jun 2025 | ||
| GUER | Guerrilla RF, Inc. | Common Shares | 7.7% | $800,000 | 800,000 | Bleichroeder LP | 19 Mar 2025 | ||
| CMPO | CompoSecure, Inc. | Class A Common Stock, $0.0001 par value per share | 4.7% | $43,808,462 | 3,897,550 | Bleichroeder LP | 30 Sep 2024 | ||
| CLRB | Cellectar Biosciences, Inc. | Common Shares | 4.6% | $760,000 | 200,000 | 0% | Bleichroeder LP | 31 Dec 2025 | |
| SMTK | SmartKem, Inc. | Common Shares | 4.1% | $389,199 | 231,666 | 0% | Bleichroeder LP | 30 Sep 2025 | |
| APTO | Aptose Biosciences Inc. | Common Shares | 1.6% | $4,583 | -$13,350 | 41,666 | -74% | Bleichroeder LP | 30 Jun 2025 |
Schedules 13D/G Reported by Bleichroeder LP:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.